In the original article, there was a mistake in Figure 6G as published. The label of Figure 6G should be HUH7 instead of HUH7-p65. The corrected Figure 6 appears below.
In the original article, there was a mistake in Figure 7 E, F as published. During the last round of revisions, we uploaded the wrong version of the file, resulting in a complete repetition of images E, F and C, D. “E, F” should have been the result of the HUH7 cell line. The corrected Figure 7 appears below.
Figure 6
Figure 7
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
hepatocellular carcinoma, LINC01667, diagnostic biomarker, overall survival, carcinogenesis
Citation
Zhang K, Liu H, Yu M, Zhao H, Yang N, Bi X, Sun L, Lin R and Lü G (2021) Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma. Front. Oncol. 11:785394. doi: 10.3389/fonc.2021.785394
Received
29 September 2021
Accepted
30 September 2021
Published
15 October 2021
Volume
11 - 2021
Edited and reviewed by
Fei-Ting Hsu, China Medical University, Taiwan
Updates
Copyright
© 2021 Zhang, Liu, Yu, Zhao, Yang, Bi, Sun, Lin and Lü.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guodong Lü, lgd_xj@qq.com; Renyong Lin, renyonglin@xjmu.edu.cn
†These authors have contributed equally to this work and share first authorship
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.